Epi Check & Inject
Updated: Jul 24, 2019
The cost of readiness measured against the number of patients with anaphylaxis means that for most agencies, Epi Pens can be one of the most costly items to keep in stock. Add in the potential for injury secondary to administration and provider failure to aggressively treat anaphylaxis. The result is a system that is set up for failure. The Epi Check & Inject program enables Services to overcome these challenges through simple clinical, operational, and educational enhancements.